Accessed May 31, 2020
Results GLP-1s reduce body weight by 518 % in trials, with modestly lower effects in real-world analyses, with multiple demonstrated clinical benefits
Recent studies have shown that GLP-1(936) is particularly effective at low glucose concentrations, with its inhibitory effect being similar to that of GLP-1(7-36)
Strength Metabolic GLP-3 Retatrutide Retatrutide (LY3437943) is an investigational triple agonist at the GLP-1, GIP, and glucagon receptors, studied for metabolic research
Losing significant lean mass during a retatrutide course undermines the long-term metabolic benefit of the weight loss itself
You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition